Sort
8,912 grants matching “sars cov 2”
MRI: Track 1 Acquisition of 600 MHz NMR for Growth in Scientific Research, Education, and Economic Impact
$1,236,425Pavel Anzenbacher · Bowling Green State University · · FY2024 · MPS
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection
$1,235,421Akiko Iwasaki · Yale University · R01 · FY2022 · AI
IP21-002 US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,234,285Mary A Staat · Cincinnati Childrens Hosp Med Ctr · U01 · FY2024 · IP
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
$1,234,285Natasha Bassam Halasa · Vanderbilt University Medical Center · U01 · FY2024 · IP
IP21-002, New Vaccine Surveillance Network
$1,234,285Marian G Michaels · University Of Pittsburgh At Pittsburgh · U01 · FY2024 · IP
IP21-002, Surveillance for Vaccine Preventable Disease in Children
$1,234,285Julie Anne Boom · Baylor College Of Medicine · U01 · FY2024 · IP
IP21-002, Enhanced Surveillance to Assess Vaccine Preventable Enteric and Respiratory Virus Illnesses
$1,234,285Janet A Englund · Seattle Children'S Hospital · U01 · FY2024 · IP
IP21-002, Enhanced Surveillance Network for Enteric and Respiratory Viruses in Children: Assessing Disease Burden, Natural History, and Vaccine Effectiveness
$1,234,285Geoffrey Alan Weinberg · University Of Rochester · U01 · FY2024 · IP
IP21-002, US Enhanced Surveillance Network to Assess Burden, Natural History, and Effectiveness of Vaccines to Prevent Enteric and Respiratory Viruses in Children
$1,234,285Rangaraj Selvarangan · Children'S Mercy Hosp (Kansas City, Mo) · U01 · FY2024 · IP
Population-based survey of SARS-CoV-2 infection and immune response
$1,232,994Aaron Julius Siegler · Emory University · R01 · FY2021 · AI
Mechanisms Of Immune Mediated Restriction Of HIV Replication In LTNP
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mechanisms of Effective Humoral Immune Responses to HIV-1
$1,230,841Mark Connors · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Community network driven COVID-19 testing of vulnerable populations in the Central US
$1,230,295Harold Alexander Pollack · University Of Chicago · UG1 · FY2022 · DA
Viral and immune-mediated CNS pathology during SARS-CoV-2 infection
$1,230,201Akiko Iwasaki · Yale University · R01 · FY2023 · AI
Predictors of Recidivism to Obesity in Weight-Reduced Individuals
$1,227,926Rudolph L Leibel · Columbia University Health Sciences · UH3 · FY2022 · DK
Immunogenicity and Efficacy of SARS-CoV-2 stabilized prefusion Spike protein vaccines in infant rhesus macaques
$1,227,827Sallie R. Permar · Duke University · P01 · FY2020 · AI
Mechanisms Of Humoral Evasion
$1,227,402Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2023 · AI
FY21 ITCA NARCH XI
$1,226,557Maria Dadgar · Inter Tribal Council Of Arizona, Inc. · S06 · FY2022 · GM
COVID-19 testing and vaccination social network diffusion for diverse criminal legal involved communities
$1,226,130John Schneider · University Of Chicago · U01 · FY2022 · MD
Facility Management, Maintenance and Operation Core
$1,225,794Raymond Paul Goodrich · Colorado State University · UC7 · FY2025 · AI
Clinical evaluation of SARS-CoV-2 subunit vaccine in a Phase I human clinical study
$1,225,641Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2020 · AI
NIA AD/ADRD Health Care Systems Research Collaboratory
$1,223,258Vincent Mor · Brown University · U54 · FY2021 · AG
Wirelessly controlled BSL3 vivarium system for automated microdosing in studies of infectious diseases
$1,222,524Tuan Q Hoang · Fluid Synchrony, Llc · R44 · FY2022 · OD
Rapid response for pandemics: single cell sequencing and deep learning to predict antibody sequences against an emerging antigen
$1,219,945Animesh Ray · Keck Graduate Inst Of Applied Life Scis · R01 · FY2023 · AI
Single-molecule dynamics in solution with anti-Brownian trapping
$1,217,231Quan Wang · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK